Never change your prescribed dose without talking to your medical team first
Rebalance Your Body, Reignite Your Life Targeted hormone therapy to restore balance naturally Say goodbye to fatigue, mood swings, and hormonal chaos
Changes in UACR were analyzed as the average difference between the log-transformed baseline value and the log-transformed week 104 value, with the exponentiated difference between the differences in log-transformed values (baseline and week 104) for each treatment group
References SURMOUNT-5 head-to-head trial (NEJM, May 2025) summary via American College of Cardiology: SURPASS-2 primary publication (NEJM, 2021): Eli Lilly SURMOUNT-1 results announcement (NEJM data): Insights into the Mechanism of Action of Tirzepatide (PMC narrative review): Tirzepatide is an imbalanced and biased dual GIP/GLP-1 receptor agonist (PMC): SURMOUNT-5 GI tolerability / discontinuation data (Applied Clinical Trials, tctmd, DiabetesontheNet coverage): SURMOUNT-1 to -4 GI tolerability (Rubino 2025, Diabetes Obesity & Metabolism): Community sentiment context Reddit GLP-1 side-effect analysis and comparative meta-analyses (PMC): Research Use Only Notice: The content on this page is provided for informational and educational purposes only
Youve developed some new health conditions: If you develop certain health conditions, such as thyroid cancer, your provider may recommend you stop taking semaglutide, since its not recommended for people with those conditions
